Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery-Reference-Cited by-同舟云学术

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Published:2017-03-09 Issue:16 Volume:8 Page:27145-27154
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bryce Alan H.¹²³,Egan Jan B.³,Borad Mitesh J.¹²³,Stewart A. Keith¹²³,Nowakowski Grzegorz S.³⁴,Chanan-Khan Asher³⁵,Patnaik Mrinal M.³⁴,Ansell Stephen M.³⁴,Banck Michaela S.³⁶,Robinson Steven I.³⁶,Mansfield Aaron S.³⁶,Klee Eric W.³⁷,Oliver Gavin R.³⁷,McCormick Jennifer B.⁷,Huneke Norine E.³,Tagtow Colleen M.³,Jenkins Robert B.⁸,Rumilla Kandelaria M.⁸,Kerr Sarah E.⁹,Kocher Jean-Pierre A.³⁷,Beck Scott A.³,Fernandez-Zapico Martin E.¹⁰,Farrugia Gianrico³¹¹,Lazaridis Konstantinos N.³¹¹,McWilliams Robert R.³⁶¹²

Affiliation:

1. Hematology/Oncology, Mayo Clinic, Phoenix, AZ, U.S.A

2. Mayo Clinic Cancer Center, Phoenix, AZ, U.S.A

3. Center for Individualized Medicine, Mayo Clinic, Rochester, MN, U.S.A

4. Hematology, Mayo Clinic, Rochester, MN, U.S.A

5. Hematology/Oncology, Mayo Clinic, Jacksonville, FL, U.S.A

6. Medical Oncology, Mayo Clinic, Rochester, MN, U.S.A

7. Health Sciences Research, Mayo Clinic, Rochester, MN, U.S.A

8. Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, U.S.A

9. Anatomic Pathology, Mayo Clinic, Rochester, MN, U.S.A

10. Schulze Center for Novel Therapeutics, Division of Oncology Research, Medical Oncology, Mayo Clinic, Rochester, MN, U.S.A

11. Gastroenterology, Mayo Clinic, Rochester, MN, U.S.A